1. Home
  2. NVAX vs NRP Comparison

NVAX vs NRP Comparison

Compare NVAX & NRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • NRP
  • Stock Information
  • Founded
  • NVAX 1987
  • NRP 2002
  • Country
  • NVAX United States
  • NRP United States
  • Employees
  • NVAX N/A
  • NRP N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • NRP Coal Mining
  • Sector
  • NVAX Health Care
  • NRP Energy
  • Exchange
  • NVAX Nasdaq
  • NRP Nasdaq
  • Market Cap
  • NVAX 1.3B
  • NRP 1.3B
  • IPO Year
  • NVAX 1995
  • NRP N/A
  • Fundamental
  • Price
  • NVAX $6.47
  • NRP $95.22
  • Analyst Decision
  • NVAX Buy
  • NRP
  • Analyst Count
  • NVAX 5
  • NRP 0
  • Target Price
  • NVAX $16.60
  • NRP N/A
  • AVG Volume (30 Days)
  • NVAX 6.2M
  • NRP 23.6K
  • Earning Date
  • NVAX 08-07-2025
  • NRP 08-06-2025
  • Dividend Yield
  • NVAX N/A
  • NRP 4.43%
  • EPS Growth
  • NVAX N/A
  • NRP N/A
  • EPS
  • NVAX 2.97
  • NRP 10.41
  • Revenue
  • NVAX $1,254,962,000.00
  • NRP $229,909,000.00
  • Revenue This Year
  • NVAX $56.85
  • NRP N/A
  • Revenue Next Year
  • NVAX N/A
  • NRP N/A
  • P/E Ratio
  • NVAX $2.17
  • NRP $9.13
  • Revenue Growth
  • NVAX 25.92
  • NRP N/A
  • 52 Week Low
  • NVAX $5.01
  • NRP $81.74
  • 52 Week High
  • NVAX $17.81
  • NRP $113.04
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 39.95
  • NRP 44.47
  • Support Level
  • NVAX $6.26
  • NRP $94.64
  • Resistance Level
  • NVAX $7.80
  • NRP $99.00
  • Average True Range (ATR)
  • NVAX 0.36
  • NRP 2.68
  • MACD
  • NVAX -0.13
  • NRP -0.00
  • Stochastic Oscillator
  • NVAX 1.62
  • NRP 19.77

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About NRP Natural Resource Partners LP Limited Partnership

Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. The business activity of the group functions through the United States.

Share on Social Networks: